Benzinga's Top Upgrades

Analysts at KeyBanc upgraded Ashland ASH from “hold” to “buy.” The target price for Ashland is set to $136. Ashland's shares closed at $107.18 on Friday. Wells Fargo upgraded BioCryst Pharmaceuticals BCRX from “market perform” to “outperform.” BioCryst Pharmaceuticals' shares closed at $11.84 on Friday. Analysts at Stifel Nicolaus upgraded LaSalle Hotel Properties LHO from “hold” to “buy.” The target price for LaSalle Hotel Properties is set to $37. LaSalle Hotel's shares closed at $35.50 on Friday. Analysts at Goldman Sachs upgraded Burlington Stores BURL from “neutral” to “buy.” The target price for Burlington Stores has been raised from $33 to $37. Burlington's shares closed at $31.60 on Friday.